Join
Live feed
·
PRReleasevia Quantisnow
Myovant Sciences Ltd. logo
Pfizer Inc. logo

Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis

ByQuantisnow·Wall Street's wire, on your screen.
MYOV· Myovant Sciences Ltd.PFE· Pfizer Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYOV (Myovant Sciences Ltd.), PFE (Pfizer Inc.) and more on Quantisnow.